MARKET

SEER

SEER

Seer, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

84.06
+0.29
+0.35%
After Hours: 85.00 +0.94 +1.12% 17:29 01/20 EST
OPEN
83.77
PREV CLOSE
83.77
HIGH
85.00
LOW
75.17
VOLUME
208.36K
TURNOVER
--
52 WEEK HIGH
86.55
52 WEEK LOW
44.00
MARKET CAP
4.91B
P/E (TTM)
-300.0000
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
W.R. Grace, GameStop See Activist Action
40 North Management, which owns a large stake in W.R. Grace, raised its bid for the company. RC Ventures reached an agreement to appoint three directors to the board of videogaming retailer GameStop.
Barrons.com · 5d ago
Maverick Capital Management Reports In 13D Filing A 10.4% Stake In Seer
-SEC Filing-SEC Filing
SEC Filing-SEC Filing · 01/11 22:18
Seer, Bruker sign commercial agreement for proteomics
Seer ([[SEER]]) have signed a non-exclusive commercial agreement with Bruker, one of the world’s leading analytical instrumentation companies.This agreement will enable Seer to market the timsTOF Pro mass spectrometer system
Seekingalpha · 01/11 14:37
Seer Signs Commercial Agreement to Provide Complete End-to-End Solution for Unbiased, Deep, Rapid and Large-Scale Proteomics
Seer (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today that it has signed a non-exclusive commercial agreement with Thermo Fisher Scientific, a world leader in serving science, for Seer to off...
GlobeNewswire · 01/11 13:05
Seer and Bruker Sign Commercial Agreement to Expand Market for Unbiased, Deep Proteomics
Seer (NASDAQ:SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today that they have signed a non-exclusive commercial agreement with Bruker Corporation, one of the
Benzinga · 01/11 13:01
Seer and Bruker Sign Commercial Agreement to Expand Market for Unbiased, Deep Proteomics
Seer (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today that they have signed a non-exclusive commercial agreement with Bruker Corporation, one of the world's leading analytical instrumentation...
GlobeNewswire · 01/11 13:00
Seer to Present at the 39th Annual J.P. Morgan Healthcare Conference
Seer, Inc. (Nasdaq: SEER), a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable proteomics information, today announced the company will be participating in the upcoming 39 Annu...
GlobeNewswire · 01/04 21:05
Seer to Present at the 39th Annual J.P. Morgan Healthcare Conference
REDWOOD CITY, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable proteomics information, today announced t...
GlobeNewswire · 01/04 21:05
More
Forecast
EPSBVPSCFPS
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SEER. Analyze the recent business situations of Seer, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SEER stock price target is 69.67 with a high estimate of 75.00 and a low estimate of 65.00.
Institutional Holdings
Institutions: 1
Institutional Holdings: 750
% Owned: 0.00%
Shares Outstanding: 58.44M
TypeInstitutionsShares
Increased
0
0
New
1
750
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Office Equipment
+1.99%
Technology Equipment
+1.27%
Key Executives
President
Philip Ma
Chief Executive Officer/Primary Contact
Omid Farokhzad
Vice President
Bill Manning
Vice President
Asim Siddiqui
Vice President
Greg Troiano
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SEER
Seer, Inc. is a life sciences technology company. The Company enables scientific outcomes by commercializing products for researchers to unlock biological information. Its initial product, the Proteograph Product Suite (Proteograph), uses its engineered nanoparticle (NP) technology to provide access across the proteome. Its Proteograph Product Suite is an integrated solution that is comprised of consumables, an automation instrument and software. Proteograph provides a workflow, which enables proteomic profiling and the analysis of samples needed to characterize the nature of the proteome. The Company's Proteograph consumables consist of its NP panel and other consumables necessary to assay samples on its automation instrument. Its Proteograph automation instrument is custom-configured liquid handling workstation. The Company's Proteograph Instrument Control Software (PICS) for the Proteograph is fixed and designed to its specified workflow.
More

Webull offers kinds of Seer Inc stock information, including NASDAQ:SEER real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SEER stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SEER stock methods without spending real money on the virtual paper trading platform.